TrialJournal of hematology & oncology2016

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery.

Michael M B Green et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.